COVID-19 / CORONA VIRUS NOTICE TO MEDICAL PRACTIONERS:
READ: Modified Human Serum Albumin Albumin as Therapeutic in COVID-19 Patients.
Currently, Systmedical is working with critical care specialists and governmental personnel to confirm the efficacy of its proprietary formulation of human serum albumin and amino acids as a countermeasure and the therapeutic treatment of COVID-19 / Corona Virus patients. Systemedical is granting royalty-free use for a period of 1 year for all medical groups and medical professionals treating COVID-19. Please contact us for information on permissions and protocols. Case Reports and hypothesis regarding efficacy as therapeutic for COVID-19 can be found HERE.
IMMUNITY FROM LIABILITY: Licensed Health professionals or other persons authorized to prescribe, administer or dispense COVID-19 countermeasures are immune from liability under Federal Law. Read the Federal Declaration for applicability HERE.
A New Paradigm in Sepsis Management
“Over the last 2 to 3 decades, billions of dollars have been spent on sepsis research, with over 7000 publications since 2006 alone and not a single new therapeutic agent has been implemented into clinical practice.” Journal of Pediatric Critical Care: Argent A; Kisson N: Vol. 18 No 6 pp 590, June 2017 (Editorial)
Since the year 2000, Systemedical has been focused on creating and developing new ideas in the fields of critical care medicine, pharmacology, and general therapeutic practices.
Field of Focus:
Critical Care Medicine
Standards of care in critical care medicine have been slow to respond to change - particularly in the field of fluid therapy for critically ill patients. The primary focus of Systemedical has been to analyze, study and develop alternative fluid therapy treatment and protocols. Systemedical holds the exclusive rights to the proprietary patented formulation rights to the combination of Human Serum Albumin and Amino Acid Solution for the treatment of acute hypovolemia due to any number of medical conditions due to spesis with shock, hemorrhagic shock, hypovolemic shock, burn injury, capilary leak syndrome, hypoalbuminemia, nephritic syndrom, or multi-organ failure with third space fluid loss from any other medical disease. This formulation was developed by Dr. William Norberg, a critical care specialist and is known as “The Norberg Solution” or TNS.
“We must all obey the great law of change. It is the most powerful law of nature.”
– Edmund Burke
Contact Us
Information regarding permissions and treatment protocols can be obtained from contacting us directly.